Wagenmakers M A E M, Netea-Maier R T, van Lindert E J, Timmers H J L M, Grotenhuis J A, Hermus A R M M
Pituitary Centre Nijmegen, Department of Endocrinology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Clin Endocrinol (Oxf). 2009 Feb;70(2):274-80. doi: 10.1111/j.1365-2265.2008.03334.x.
No data on results of repeated transsphenoidal surgery via the endoscopic technique for patients with persistent or recurrent Cushing's disease are available.
We retrospectively evaluated the remission rates and complications of repeated transsphenoidal surgery via the endoscopic technique in 14 patients with persistent (N = 6) or recurrent (N = 8) Cushing's disease treated in our centre between 1999 and 2007.
Remission was defined as the disappearance of symptoms of hypercortisolism with basal plasma cortisol level < or = 50 nmol/l 24-48 h after glucocorticoid withdrawal and/or suppression of plasma cortisol level < or = 50 nmol/l after 1 mg dexamethasone overnight within the first 3 months after transsphenoidal surgery.
With repeated endoscopic transsphenoidal surgery a remission rate of 10/14 (71%) was achieved. No patient had a relapse during a median follow-up of 24 months. Cerebrospinal fluid leakage was the most frequent complication (6 patients) and 11 patients required hormonal substitution after surgery. The success of repeated transsphenoidal surgery could not be predicted by visualization of an adenoma on MRI before first or second surgery, histopathological confirmation of an ACTH secreting adenoma after first or second surgery, treatment with cortisol lowering agents before first or second surgery, the operation technique used during the first surgery, persistent vs. recurrent disease after the first surgery, age, gender and interval between the two surgeries.
Repeated transsphenoidal surgery via the endoscopic technique is a good treatment option for selected patients with recurrent or persistent Cushing's disease following primary pituitary surgery.
目前尚无关于经内镜技术对持续性或复发性库欣病患者进行重复经蝶窦手术结果的数据。
我们回顾性评估了1999年至2007年间在本中心接受治疗的14例持续性(n = 6)或复发性(n = 8)库欣病患者经内镜技术重复经蝶窦手术的缓解率和并发症。
缓解定义为糖皮质激素撤药后24 - 48小时基础血浆皮质醇水平≤50 nmol/l且高皮质醇血症症状消失,和/或经蝶窦手术后前3个月内1毫克地塞米松过夜后血浆皮质醇水平抑制≤50 nmol/l。
通过重复内镜经蝶窦手术,缓解率达到10/14(71%)。在中位随访24个月期间,无患者复发。脑脊液漏是最常见的并发症(6例患者),11例患者术后需要激素替代治疗。首次或第二次手术前MRI上腺瘤的可视化、首次或第二次手术后促肾上腺皮质激素分泌腺瘤的组织病理学证实、首次或第二次手术前使用降低皮质醇药物治疗、首次手术中使用的手术技术、首次手术后持续性与复发性疾病、年龄、性别以及两次手术之间的间隔时间,均无法预测重复经蝶窦手术的成功与否。
对于原发性垂体手术后复发性或持续性库欣病的特定患者,经内镜技术重复经蝶窦手术是一种良好的治疗选择。